Al-Khlaiwi T, Habib SS, Bayoumy N, Al-Khliwi H, Meo SA. Identifying risk factors and mortality rate of premature coronary artery disease in young Saudi population. Sci Rep. 2024;14(1):12727.

Article  PubMed  PubMed Central  Google Scholar 

Tutar M, Kocak HG, Kocak M. Geographical variations and predictors of coronary artery disease mortality in turkiye: an environmental and behavioral analysis. BMC Cardiovasc Disord. 2024;24(1):554.

Article  PubMed  PubMed Central  Google Scholar 

Güven C, Kafadar H. Evaluation of plasma Asprosin concentration in patients with coronary artery disease. Braz J Cardiovasc Surg. 2022;37:493–500.

Article  PubMed  PubMed Central  Google Scholar 

Moradi N, Fouani FZ, Vatannejad A, Bakhti Arani A, Shahrzad S, Fadaei R. Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study. Lipids Health Dis. 2021;20(1):88.

Article  PubMed  PubMed Central  Google Scholar 

Askin L, Tanriverdi O, Tibilli H, Turkmen S. Associations between vaspin levels and coronary artery disease. Cardiovasc Innov Appl. 2020;4(3):211.

Google Scholar 

Pilarski Ł, Pelczyńska M, Koperska A, Seraszek-Jaros A, Szulińska M, Bogdański P. Association of serum vaspin concentration with metabolic disorders in obese individuals. Biomolecules. 2023;13(3):508.

Article  PubMed  PubMed Central  Google Scholar 

Luo J, He Z, Li Q, Lv M, Cai Y, Ke W, et al. Adipokines in atherosclerosis: unraveling complex roles. Front Cardiovasc Med. 2023;10:1235953.

Article  PubMed  PubMed Central  Google Scholar 

Akcılar R, Yümün G, Bayat Z, et al. Association of Vaspin rs2236242 gene variants and circulating serum Vaspin concentrations with coronary artery disease in a Turkish population. J Cell Physiol. 2021;236(5):3734–9.

Article  PubMed  Google Scholar 

Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, Park YJ, et al. Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol. 2011;75(5):628–35.

Article  Google Scholar 

Danuaji R, Suroto S, Purwanto B, Indarto D, Muhammad F, Mirawati DK, et al. Serum Vaspin role in atherosclerosis and glucose tolerance disorders: a systematic review and meta-analysis. J Appl Pharm Sci. 2023;13(01):024–41.

Google Scholar 

Kurowska P, Mlyczyńska E, Dawid M, Jurek M, Klimczyk D, Dupont J, et al. Vaspin (SERPINA12) expression and function in endocrine cells. Cells. 2021;10(7):1710.

Article  PubMed  PubMed Central  Google Scholar 

Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: a novel player in metabolic diseases. Front Endocrinol. 2020;11:512762.

Article  Google Scholar 

Zhong M, Tian X, Sun Q, Li L, Lu Y, Feng Z, et al. Correlation of Asprosin and Nrg-4 with type 2 diabetes mellitus complicated with coronary heart disease and the diagnostic value. BMC Endocr Disord. 2023;23(1):61.

Article  PubMed  PubMed Central  Google Scholar 

Jung TW, Kim HC, Kim HU, Park T, Park J, Kim U, et al. Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle. J Cell Physiol. 2019;234(11):20888–99.

Article  PubMed  Google Scholar 

Chikwe J, Lee T, Itagaki S, Adams DH, Egorova NN. Long-term outcomes after off-pump versus on-pump coronary artery bypass grafting by experienced surgeons. J Am Coll Cardiol. 2018;72(13):1478–86.

Article  PubMed  Google Scholar 

Németh Á, Cziráki A, Sulyok E, Horváth IG, Alotti N, Rauh M, et al. Short-term response of metabolic hormones to coronary artery bypass surgery. Adv Med Sci. 2014;59(2):213–20.

Article  PubMed  Google Scholar 

Saracevic A, Medved I, Vlah SH, Kozmar A, Bilic-Zulle L, Simundic A-M. The association of systemic inflammatory markers with indicators of stress and cardiac necrosis in patients undergoing aortic valve replacement and revascularization surgeries. Physiol Res. 2020;69(2):261.

Article  PubMed  PubMed Central  Google Scholar 

Kim J-E, Kim J-S, Jo M-J, Cho E, Ahn S-Y, Kwon Y-J, et al. The roles and associated mechanisms of adipokines in development of metabolic syndrome. Molecules. 2022;27(2):334.

Article  PubMed  PubMed Central  Google Scholar 

Kobat MA, Celik A, Balin M, Altas Y, Baydas A, Bulut M, et al. The investigation of serum Vaspin level in atherosclerotic coronary artery disease. J Clin Med Res. 2012;4(2):110.

PubMed  PubMed Central  Google Scholar 

Hao F, Zhang H, Zhu J, Kuang H, Yu Q, Bai M, et al. Association between vaspin level and coronary artery disease in patients with type 2 diabetes. Diabetes Res Clin Pract. 2016;113:26–32.

Article  PubMed  Google Scholar 

Sato K, Shirai R, Yamaguchi M, Yamashita T, Shibata K, Okano T, et al. Anti-atherogenic effects of Vaspin on human aortic smooth muscle cell/macrophage responses and hyperlipidemic mouse plaque phenotype. Int J Mol Sci. 2018;19(6):1732.

Article  PubMed  PubMed Central  Google Scholar 

Zhou X, Chen Y, Tao Y, Zhang W, Xu W, Lu X. Serum vaspin as a predictor of adverse cardiac events in acute myocardial infarction. J Am Heart Assoc. 2019;8(2):e010934.

Article  PubMed  PubMed Central  Google Scholar 

Breitfeld J, Wiele N, Gutsmann B, Stumvoll M, Blüher M, Scholz M, et al. Circulating adipokine VASPIN is associated with serum lipid profiles in humans. Lipids. 2019;54(4):203–10.

Article  PubMed  Google Scholar 

Breitfeld J, Horn K, Le Duc D, Velluva A, Marzi C, Grallert H, et al. Genetic dissection of serum Vaspin highlights its causal role in lipid metabolism. Obesity. 2023;31(11):2862–74.

Article  PubMed  Google Scholar 

Gao J-H, Zeng M-Y, Yu X-H, Zeng G-F, He L-H, Zheng X-L, et al. Visceral adipose tissue-derived serine protease inhibitor accelerates cholesterol efflux by up-regulating ABCA1 expression via the NF-κB/miR-33a pathway in THP-1 macropahge-derived foam cells. Biochem Biophys Res Commun. 2018;500(2):318–24.

Article  PubMed  Google Scholar 

Wen M-S, Wang C-Y, Yeh J-K, Chen C-C, Tsai M-L, Ho M-Y, et al. The role of Asprosin in patients with dilated cardiomyopathy. BMC Cardiovasc Disord. 2020;20(1):402.

Article  PubMed  PubMed Central  Google Scholar 

Shabir K, Gharanei S, Orton S, Patel V, Chauhan P, Karteris E, et al. Asprosin exerts pro-inflammatory effects in THP-1 macrophages mediated via the toll-like receptor 4 (TLR4) pathway. Int J Mol Sci. 2022;24(1):227.

Article  PubMed  PubMed Central  Google Scholar 

Zou J, Xu C, Zhao Z-W, Yin S-H, Wang G. Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway. J Transl Med. 2022;20(1):337.

Article  PubMed  PubMed Central  Google Scholar 

Ciftci H, Gul HF, Sahin L, Dolanbay T, Canacik O, Karsli E, et al. Serum myeloperoxidase, paraoxonase, and plasma asprosin concentrations in patients with acute myocardial infarction. Heliyon. 2024. https://doi.org/10.1016/j.heliyon.2024.e29465.

Article  PubMed  PubMed Central  Google Scholar 

Gül SNS, Birdal O, Laloğlu E. Serum Asprosin levels are increased in patients with periodontitis and ST-segment elevation myocardial infarction and correlated with periodontal parameters: a case–control study. J Periodontal Res. 2024;59(2):259–66.

Article  PubMed  Google Scholar